Anti-PSMA/CD3 Bispecific Antibody Delivery and Antitumor Activity Using a Polymeric Depot Formulation
September 20, 2020
Previous PostPoly(ethylene glycol)-b-poly(1,3-trimethylene carbonate) Amphiphilic Copolymers for Long-Acting Injectables: Synthesis, Non-Acylating Performance and In Vivo Degradation
Next PostEffects of an injectable long-acting formulation of ivermectin on Onchocerca ochengi in zebu cattle